Key terms

About ATRA

Atara Biotherapeutics, Inc. is an allogeneic T-cell immunotherapy company, which engages in the development of transformative therapies for patients with serious diseases including solid tumors, hematologic cancers, and autoimmune diseases. It also delivers off-the-shelf treatments to patients with high unmet medical need. Its product pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in Thousand Oaks, CA.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest ATRA news

Today 8:15am ET Buy Rating Affirmed for Atara Biotherapeutics on Strong Pipeline and Financial Health by TipRanks Apr 01 7:30am ET Analysts Offer Insights on Healthcare Companies: Atara Biotherapeutics (ATRA) and Embecta Corporation (EMBC) by TipRanks Apr 01 7:25am ET Atara Biotherapeutics price target lowered to $2.30 from $4.80 at Stifel by TipRanks Mar 31 10:20pm ET Analysts Offer Insights on Healthcare Companies: Affimed (AFMD) and Atara Biotherapeutics (ATRA) by TipRanks Mar 29 4:43pm ET Atara Biotherapeutics Board Member Decides Not to Seek Re-Election by TipRanks Mar 29 2:00am ET Atara Biotherapeutics’ Profitability Hinges on Partners’ Success with Ebvallo Amid Market Challenges by TipRanks Mar 28 4:06pm ET Atara Biotherapeutics (ATRA) Gets a Buy from TD Cowen by TipRanks Mar 01 8:00am ET Analysts Offer Insights on Healthcare Companies: Atara Biotherapeutics (ATRA), Moderna (MRNA) and Madrigal Pharmaceuticals (MDGL) by TipRanks Feb 29 9:21am ET FDA clears Atara’s IND application in LN for allogeneic CAR T therapy ATA3219 by TipRanks Feb 24 10:07am ET Atara Biotherapeutics Restructures, CMO Transitions to Consultant by TipRanks Feb 14 9:09am ET Atara Biotherapeutics submits IND for ATA3219 to treat Lupus Nephriti by TipRanks

No recent press releases are available for ATRA

ATRA Financials

1-year income & revenue

Key terms

ATRA Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

ATRA Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms

Latest investing news

NEW YORK, NEW YORK - MAY 03: Traders work on the floor of the New York Stock Exchange (NYSE) on May 03, 2024 in New York City. The Dow surged over 400 points in morning trading as new economic numbers showed that the central bank may cut interest rates sooner than expected. (Photo by Spencer Platt/Getty Images)
Spencer Platt/Getty Images North America/Getty Images
There’s a surprising bit of good news lurking in the stock market
Bruce Garelick was found guilty of insider trading
John Minchillo/AP
Investor found guilty in Trump Media insider trading case
People walk toward an entrance to Disneyland in Anaheim, California on April 24, 2023.
Mario Tama/Getty Images/File
Americans are shopping less but they’re still spending on flights, hotels and Disneyland
Scaffolding and construction netting near an apartment building in New York, US, on Wednesday, Oct. 11, 2023. Monthly fees and expenses for inspections, insurance and climate-friendly upgrades are squeezing residents of the city's many co-op and condo buildings. Photographer: Michael Nagle/Bloomberg
Michael Nagle/Bloomberg/Getty Images
For US renters, the chance of owning a home is going from bad to worse